Status | 已發表Published |
Coptidis rhizome and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity | |
Meng, F.; Wu, Z.; Yin, Z.; Lin, L.; Wang, R.; Zhang, Q. W. | |
2018-05-07 | |
Source Publication | Chinese Medicine |
ISSN | 1749-8546 |
Pages | 13-13 |
Abstract | Background Coptidis rhizoma (CR) is the dried rhizome of Coptis chinensis Franch., C. deltoidea C. Y. Cheng et Hsiao or C. teeta Wall. (Ranunculaceae) and is commonly used in Traditional Chinese Medicine for the treatment of various diseases including bacillary dysentery, typhoid, tuberculosis, epidemic cerebrospinal meningitis, empyrosis, pertussis, and other illnesses. Methods A literature survey was conducted via SciFinder, ScieneDirect, PubMed, Springer, and Wiley databases. A total of 139 selected references were classified on the basis of their research scopes, including chemical investigation, quality evaluation and pharmacological studies. Results Many types of secondary metabolites including alkaloids, lignans, phenylpropanoids, flavonoids, phenolic compounds, saccharides, and steroids have been isolated from CR. Among them, protoberberine-type alkaloids, such as berberine, palmatine, coptisine, epiberberine, jatrorrhizine, columamine, are the main components of CR. Quantitative determination of these alkaloids is a very important aspect in the quality evaluation of CR. In recent years, with the advances in isolation and detection technologies, many new instruments and methods have been developed for the quantitative and qualitative analysis of the main alkaloids from CR. The quality control of CR has provided safety for pharmacological applications. These quality evaluation methods are also frequently employed to screen the active components from CR. Various investigations have shown that CR and its main alkaloids exhibited many powerful pharmacological effects including anti-inflammatory, anti-cancer, anti-diabetic, neuroprotective, cardioprotective, hypoglycemic, anti-Alzheimer and hepatoprotective activities. Conclusion This review summarizes the recent phytochemical investigations, quality evaluation methods, the biological studies focusing on CR as well as its main alkaloids. |
Keyword | Coptidis rhizoma Coptis genus Phytochemistry Quality evaluation Pharmacological effects |
Language | 英語English |
The Source to Article | PB_Publication |
PUB ID | 36256 |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Wang, R.; Zhang, Q. W. |
Recommended Citation GB/T 7714 | Meng, F.,Wu, Z.,Yin, Z.,et al. Coptidis rhizome and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity[J]. Chinese Medicine, 2018, 13-13. |
APA | Meng, F.., Wu, Z.., Yin, Z.., Lin, L.., Wang, R.., & Zhang, Q. W. (2018). Coptidis rhizome and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chinese Medicine, 13-13. |
MLA | Meng, F.,et al."Coptidis rhizome and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity".Chinese Medicine (2018):13-13. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment